• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.

作者信息

Rigolin Gian Matteo, Cavallari Maurizio, Quaglia Francesca Maria, Formigaro Luca, Lista Enrico, Urso Antonio, Guardalben Emanuele, Liberatore Carmine, Faraci Danilo, Saccenti Elena, Bassi Cristian, Lupini Laura, Bardi Maria Antonella, Volta Eleonora, Tammiso Elisa, Melandri Aurora, Negrini Massimo, Cavazzini Francesco, Cuneo Antonio

机构信息

Sezione Ematologia, Dipartimento di Scienze Mediche, Azienda Ospedaliero-Universitaria, Arcispedale S. Anna.

Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, and.

出版信息

Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26.

DOI:10.1182/blood-2017-03-772285
PMID:28446433
Abstract
摘要

相似文献

1
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.在慢性淋巴细胞白血病（CLL）中，合并症和复杂核型与较差的预后相关，且独立于CLL国际预后指数（CLL-IPI）。
Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26.
2
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.在伊布替尼 3 期临床试验中评估复发/难治性慢性淋巴细胞白血病的 CLL-IPI。
Leuk Lymphoma. 2019 Jun;60(6):1438-1446. doi: 10.1080/10428194.2018.1540782. Epub 2018 Nov 8.
3
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.临床分期的变化可识别慢性淋巴细胞白血病患者以及国际慢性淋巴细胞白血病研讨会（iwCLL）部分缓解情况下不同的预后：RESONATE研究。
Br J Haematol. 2019 Apr;185(1):148-150. doi: 10.1111/bjh.15397. Epub 2018 May 31.
4
Predicting survival in chronic lymphocytic leukemia.预测慢性淋巴细胞白血病患者的生存情况。
Expert Rev Anticancer Ther. 2012 Mar;12(3):393-403. doi: 10.1586/era.12.2.
5
Prognostic factors in chronic lymphocytic leukaemia.慢性淋巴细胞白血病的预后因素
Haematologica. 1999 Jun;84 Suppl EHA-4:96-7.
6
Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.糖尿病与慢性淋巴细胞白血病患者预后不良相关：一项倾向评分匹配分析。
Cancer Res Treat. 2020 Jan;52(1):189-206. doi: 10.4143/crt.2019.122. Epub 2019 Jul 1.
7
Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.血清β2微球蛋白和血清胸苷激酶是慢性淋巴细胞白血病和免疫细胞瘤无进展生存期的独立预测指标。
Leuk Lymphoma. 1996 Aug;22(5-6):439-47. doi: 10.3109/10428199609054782.
8
p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.在晚期Rai III/IV期B细胞慢性淋巴细胞白血病患者中，p53异常不能预测对氟达拉滨的个体反应。
Br J Haematol. 2005 Apr;129(1):53-9. doi: 10.1111/j.1365-2141.2005.05405.x.
9
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.综合慢性淋巴细胞白血病评分系统，一种预测慢性淋巴细胞白血病患者治疗时间和总生存期的新的简易指标。
Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):612-20.e1-5. doi: 10.1016/j.clml.2015.06.001. Epub 2015 Jun 20.
10
Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.比较慢性淋巴细胞白血病预后模型的评估：印度队列的评估。
Ann Hematol. 2019 Feb;98(2):437-443. doi: 10.1007/s00277-018-3525-0. Epub 2018 Oct 18.

引用本文的文献

1
Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect.单克隆B细胞淋巴细胞增多症：血液科医生不应忽视的沉默克隆
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70084. doi: 10.1002/hon.70084.
2
Cause-Specific Mortality and Prognostic Impact of Comorbidity in Japanese Patients With Chronic Lymphocytic Leukemia.日本慢性淋巴细胞白血病患者的病因特异性死亡率及合并症的预后影响
Cancer Med. 2025 Feb;14(3):e70613. doi: 10.1002/cam4.70613.
3
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype.
伴有复杂核型的慢性淋巴细胞白血病患者的管理策略
Br J Haematol. 2025 Mar;206(3):832-841. doi: 10.1111/bjh.19986. Epub 2025 Jan 6.
4
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations.与荧光原位杂交（FISH）相比，靶向测序在检测慢性淋巴细胞白血病拷贝数改变方面的效用
Cancers (Basel). 2024 Jul 3;16(13):2450. doi: 10.3390/cancers16132450.
5
An overview of prognostic markers in patients with CLL.慢性淋巴细胞白血病患者预后标志物概述。
Front Oncol. 2024 May 16;14:1371057. doi: 10.3389/fonc.2024.1371057. eCollection 2024.
6
Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL study.慢性淋巴细胞白血病患者移动健康行为干预的优化：HEALTH4CLL研究
J Cancer Surviv. 2024 Mar 13. doi: 10.1007/s11764-024-01555-w.
7
Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia.利用基因组学、转录组学和表观基因组学来了解慢性淋巴细胞白血病中的化疗免疫治疗耐药性。
Cancer Drug Resist. 2024 Feb 28;7:7. doi: 10.20517/cdr.2023.98. eCollection 2024.
8
Association of Cytogenetics Aberrations and Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting.真实世界临床环境中慢性淋巴细胞白血病患者细胞遗传学异常和突变与预后的关联
Glob Med Genet. 2024 Feb 12;11(1):59-68. doi: 10.1055/s-0044-1779668. eCollection 2024 Jan.
9
Frontline Therapy of CLL-Changing Treatment Paradigms.CLL 的一线治疗——改变治疗模式。
Curr Hematol Malig Rep. 2024 Apr;19(2):65-74. doi: 10.1007/s11899-024-00726-x. Epub 2024 Feb 10.
10
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.一线使用固定疗程依鲁替尼联合维奈克拉治疗后复发的慢性淋巴细胞白血病中BTK、BCL2和PLCG2突变的缺失
Clin Cancer Res. 2024 Feb 1;30(3):498-505. doi: 10.1158/1078-0432.CCR-22-3934.